Biography:
Mundo is a Marie Curie Fellow at the University of Limerick, Ireland, and Professor Adjunct in Molecular Pathology at the University of Nairobi, Kenya. His research is focused on novel insights into the pathogenesis of virus-associated malignancies for the development of new therapies. Mundo has contributed several important discoveries in the field: the first description of a non-canonical EBV-latency program in non-Hodgkin lymphomas (Abate et al. PLoS Pathogens, 2015); the first documented evidence of EBV in-situ in primary tumours classified as virus-negative (Mundo et al., Frontiers in Microbiology, 2017; Mundo et al, Modern Pathology, 2020; Infectious Agents and Cancer, 2022), the impact of BILF-1, a poorly studied gene with a great target therapy potential.
Title : Deciphering the impact of bilf1, a new potential target therapy encoded by Epstein-Barr virus